%0 Journal Article
%T A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma.
%A Lan X
%A Feng M
%A Lv J
%A Zhang L
%A Hu P
%A Wang Y
%A Zhang Y
%A Wang S
%A Liu C
%A Liu C
%J Front Oncol
%V 14
%N 0
%D 2024
%M 38887238
%F 5.738
%R 10.3389/fonc.2024.1364997
%X <B>UNASSIGNED: </B>Medical research continues to be extensively devoted to investigating the pathogenesis and treatment approaches of hereditary renal cancer. By aspect including researchers, institutions, countries, journals, and keywords, we conduct a bibliometric analysis of the literature pertaining to hereditary renal cancer over the last 23 years.<BR><B>UNASSIGNED: </B>From the Web of Science Core Collection, we conducted a search for publications published between January 1, 2000 and November 28, 2023. Reviews and original articles were included.<BR><B>UNASSIGNED: </B>A cumulative count of 2,194 publications met the specified criteria for inclusion. The studies of the included articles involved a collective of 2,402 institutions representing 80 countries. Notably, the United States exhibited the highest number of published documents, constituting approximately 45.49% of the total. The preeminent institution in this discipline is the National Cancer Institute (NCI), which maintains a publication volume of 8.98%. In addition to being the most prolific author (125 publications), Linehan WM's works received the highest number of citations (11,985). In a comprehensive count, 803 journals have published related articles. In the top 10 most recent occurrences were the terms "hereditary leiomyomatosis" and "fumarate hydratase."<BR><B>UNASSIGNED: </B>This is the first bibliometric analysis of the literature on hereditary renal cancer. This article offers a thorough examination of the present status of investigations concerning hereditary renal cancer during the previous 23 years.